In an increasingly complex and competitive asset management business, delegating trading to an execution specialist has gained appeal. David Beth, Jennica Ross, …
Archives for March 2021
WallachBeth Announces Completion of $4.19 Million Registered Direct Offering for Lixte Biotechnology Holdings, Inc.
WallachBeth announced the completion of a Registered Direct Offering for Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery …

